v3.26.1
Net Loss Per Share
 6 Months Ended
Jun. 30, 2026
Net Loss Per Share [Abstract]  
Net Loss Per Share

13. Net Loss Per Share

 

The Company computes net loss per share using the two-class method. The two-class method uses an earnings allocation formula that determines net loss per share for common stock and any participating securities according to dividends declared and participation rights in undistributed earnings.

 

Diluted net loss per share includes the potential dilutive effect of common stock equivalents as if such securities were converted or exercised during the period, when the effect is dilutive. Common stock equivalents include: (i) outstanding stock options and restricted stock units; (ii) common stock to be issued upon the assumed exercise of the Company’s common stock warrants; (iii) convertible preferred stock; and (iv) prior to issuance, the issuable warrants related to the Company’s March 2023 private placement financing.

 

The following table sets forth the computation of basic net loss per share of common stock (in thousands, except share and per share data):

  

    Three Months Ended
June 30,		     Six Months Ended
June 30,		  
    2025     2026     2025     2026  
Basic net (loss) per share                        
Numerator:                        
Net loss   $ (6,447 )   $ (1,722 )   $ (5,877 )   $ (14,545 )
Net loss attributable to common shares, basic     (6,447 )     (1,722 )     (5,877 )     (14,545 )
                                 
Denominator:                                
Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders, basic and diluted     12,302,059       26,917,266       11,993,663       25,421,025  
Net loss per share attributable to common stockholders, basic and diluted   $ (0.52 )   $ (0.06 )   $ (0.49 )   $ (0.57 )

 

The following outstanding shares of potentially dilutive securities were excluded from the computation of net loss per share for the periods presented because including them would have been antidilutive:

 

    Three Months Ended
June 30,		     Six Months Ended
June 30,		  
    2025     2026     2025     2026  
                         
Options to purchase common stock     1,420,714       1,968,914       1,420,714       1,968,914  
Warrants to purchase common stock     478,419       478,419       478,419       478,419  
Restricted stock units     -       1,358,577       -       1,358,577  
Common stock issuable upon conversion of Series B-1 convertible preferred stock     -       -       -       -  
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock     1,115,145       -       1,115,145       -  
Warrants to purchase convertible preferred stock     15,818,817       15,818,817       15,818,817       15,818,817  
Total     18,833,095       19,624,727       18,833,095       19,624,727